Impact of Orlistat Therapy on Weight Reduction in Morbidly Obese Patients After Implantation of the Swedish Adjustable Gastric Band
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Background Adjustable gastric banding (AGB) is frequently performed to treat morbid obesity. One problem which can occasionally develop after a restrictive procedure is consumption of a high calorie liquid diet, which may prohibit further weight loss. Orlistat, a newly developed intestinal lipase inhibitor, prevents absorption of about one-third of ingested fat. It is unknown whether patients no longer losing weight after AGB, despite further band restriction, may lose weight with addition of orlistat.Methods 38 patients were selected who had stopped losing weight 3 months before the initiation of the study, 18 +/- 6 months (mean +/- SEM) after laparoscopic AGB. Subjects were divided into 2 groups, matched for age, sex, filling volume of the band and body mass index (BMI) both at the time of surgery and start of the study (18 +/- 6 months after AGB).Results Patients in group A received dietary counseling and orlistat 120 mg TID for 8 months, while patients in group B received only dietary counseling. During the following 8 months of study, subjects in group A lost 8 +/- 3 kg in weight, whereas subjects in group B lost 3 +/- 2 kg (p < 0.01, months 18 vs 26 of study; p < 0.03, group A vs B). In 15 patients from group A the study was further extended 9 months, but interestingly, weight remained stable independent of whether orlistat was continued (n = 8) or stopped (n = 7). 4 subjects were excluded from the extension study because of additional malabsorptive bypass surgery. Subjects taking orlistat encountered only minor GI side-effects.Conclusion Orlistat appears to be useful when added in patients after AGB who are no longer losing weight, perhaps due to a high-calorie liquid diet rich in fat.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Treatment options to manage post-bariatric excess weight (regain) are scarce.”
In the citing paper
“Overall, the currently available FDA-approved weight loss drugs have been associated with relatively modest weight loss in post-bariatric patients [14, 15].”
Citations
Cites
Overweight and obesity in the United States: prevalence and trends, 1960–1994
Flegal, K., Carroll, M., Kuczmarski, R., & Johnson, C. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800541 · Cited by 3,045
Outcomes After Laparoscopic Roux-en-Y Gastric Bypass for Morbid Obesity
Schauer, P. R., Ikramuddin, S., Gourash, W., Ramanathan, R., & Luketich, J. (2000) · Annals of Surgery · doi:10.1097/00000658-200010000-00007 · Cited by 1,327
Sjöström, L., Rissanen, A., Andersen, T., Boldrin, M., Golay, A., Koppeschaar, H. P., & Krempf, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11509-4 · Cited by 1,237
Effect of sibutramine on weight maintenance after weight loss: a randomised trial
James, W. P. T., Astrup, A., Finer, N., Hilsted, J., Kopelman, P., Rössner, S., Saris, W. H. M., & Gaal, L. F. V. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03491-7 · Cited by 817
Miller, W., Koceja, D., & Hamilton, E. (1997) · International Journal of Obesity · doi:10.1038/sj.ijo.0800499 · Cited by 686
Biliopancreatic Diversion with Duodenal Switch
Marceau, P., Hould, F. ‐., Simard, S., Lebel, S., Bourque, R. ‐., Potvin, M., & Biron, S. (1998) · World Journal of Surgery · doi:10.1007/s002689900498 · Cited by 638
Treatment of Obesity by Moderate and Severe Caloric Restriction: Results of Clinical Research Trials
Wadden, T. A. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-7_part_2-199310011-00012 · Cited by 470
Late Outcome of Isolated Gastric Bypass
MacLean, L. D., Rhode, B. M., & Nohr, C. W. (2000) · Annals of Surgery · doi:10.1097/00000658-200004000-00011 · Cited by 304
Zhi, J., Melia, A. T., Guerciolini, R., Chung, J., Kinberg, J., Hauptman, J. B., & Patel, I. H. (1994) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1994.104 · Cited by 278
Silicone gastric banding a simple and effective operation for morbid obesity
Kuzmak, L. I. (1986) · Cited by 112
Cited by
Laparoscopic Swedish Adjustable Gastric Banding: a Five-Year Prospective Study
Steffen, R., Biertho, L., Ricklin, T., Piec, G., & Horber, F. F. (2003) · Obesity Surgery · doi:10.1381/096089203765887741 · Cited by 118
Self-citationTratamento de curto prazo com liraglutide no reganho de peso após cirurgia bariátrica
Pajecki, D., Halpern, A., Cercato, C., Mancini, M., Cleva, R. D., & Santo, M. A. (2013) · Revista do Colégio Brasileiro de Cirurgiões · doi:10.1590/s0100-69912013000300005 · Cited by 93
Orlistat: current status in clinical therapeutics
McClendon, K. S., Riche, D. M., & Uwaifo, G. I. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330903321485 · Cited by 93
“Orlistat also appears to have potential as an adjunct in subjects who have undergone bariatric surgery (restrictive procedures) as a strategy to sustain, maintain and/or increase associated weight loss following the surgical procedure [148].”
BackgroundLautenbach, A., Wernecke, M., Huber, T. B., Stoll, F., Wagner, J., Meyhöfer, S. M., Meyhöfer, S., & Aberle, J. (2022) · Obesity Surgery · doi:10.1007/s11695-022-06211-9 · Cited by 92
Management of failed adjustable gastric banding
Biertho, L., Steffen, R., Branson, R., Potoczna, N., Ricklin, T., Piec, G., & Horber, F. F. (2005) · Surgery · doi:10.1016/j.surg.2004.06.007 · Cited by 67
Self-citation
Metadata
- Authors
- Zoss, I., Piec, G., & Horber, F. F.
- Affiliations
- Klinik Hirslanden (CH)
- ORCID
- Horber, Fritz F.
- Venue
- Obesity Surgery
- Published
- 2002-02-01
- Volume
- 12
- Issue
- 1
- Pages
- 113-117
- ISSN
- 0960-8923 (ISSN-L)
- 1708-0428
- OpenAlex
- W2087247429
- Cited by
- 34
- References
- 12
- Citations by year
- 2025: 2 · 2024: 9 · 2023: 3 · 2022: 1 · 2021: 4 · 2020: 3 · 2019: 3 · 2016: 1 · 2013: 1
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Obesity Surgery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Health Sciences › Medicine › Surgery › Body Contouring and Surgery
- Keywords
- orlistat, gastric banding
- MeSH terms
- Orlistat, Female, Humans, Lactones, Male, Middle Aged, Obesity, Morbid, Postoperative Period, Gastroplasty, Weight Loss, Anti-Obesity Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impact of Orlistat Therapy on Weight Reduction in Morbidly Obese Patients After Implantation of the Swedish Adjustable Gastric Band. https://app.cochat.ai/papers/10.1381/096089202321144685
- The paper
- Zoss, I., Piec, G., & Horber, F. F. (2002). Impact of Orlistat Therapy on Weight Reduction in Morbidly Obese Patients After Implantation of the Swedish Adjustable Gastric Band. Obesity Surgery. https://doi.org/10.1381/096089202321144685
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.